Clinical Trial Update: Plasma Exchange for Autoimmune Autonomic Failure

View source ↗

Summary

The clinical trial evaluating plasma exchange for autoimmune autonomic ganglionopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Autonomic Ganglionopathy

Snippet

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS) | Conditions: Plasma Exchange, Autonomic Failure | Status: COMPLETED